FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dogan Fidan

Research Profile

Concepts & Ideas

Chemicals & Drugs

Activities & Behaviors

Disorders

Living Beings

Inpatients

Geographic Areas

Procedures

Coronary Balloon Angioplasty

Co-author Network

Publications

TOP 3
Edward F Ewen; Liping Zhao; Paul Kolm; Claudine Jurkovitz; Dogan Fidan; Harvey D White; Richard Gallo; William S Weintraub
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.
Edward Ewen; Zugui Zhang; Paul Kolm; Claudine Jurkovitz; Joseph Jackson; Dogan Fidan; William S Weintraub
The risk of cardiovascular events in primary care patients following an episode of severe hypertension.
Kathleen Bennett; Zubair Kabir; Michael Barry; Lesley Tilson; Dogan Fidan; Emer Shelley; Simon Capewell
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dogan Fidan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Edward F Ewen; Liping Zhao; Paul Kolm; Claudine Jurkovitz; Dogan Fidan; Harvey D White; Richard Gallo; William S Weintraub
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.
Journal of interventional cardiology 2009;22(3):266-73.
2009: Edward Ewen; Zugui Zhang; Paul Kolm; Claudine Jurkovitz; Joseph Jackson; Dogan Fidan; William S Weintraub
The risk of cardiovascular events in primary care patients following an episode of severe hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2009;11(4):175-82.
2009: Kathleen Bennett; Zubair Kabir; Michael Barry; Lesley Tilson; Dogan Fidan; Emer Shelley; Simon Capewell
Cost-effectiveness of treatments reducing coronary heart disease mortality in Ireland, 2000 to 2010.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 2009;12(1):10-5.
2008: Jenny Berg; Dogan Fidan; Peter Lindgren
Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials.
Current medical research and opinion 2008;24(7):2089-101.
2008: Anna Ringborg; Robby Nieuwlaat; Peter Lindgren; Bengt Jönsson; Dogan Fidan; Aldo P Maggioni; Jose Lopez-Sendon; Janina Stepinska; Dennis V Cokkinos; Harry J G M Crijns
Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(4):403-11.
2007: Frederick A Anderson; Maksim Zayaruzny; John A Heit; Dogan Fidan; Alexander T Cohen
Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism.
American journal of hematology 2007;82(9):777-82.
2007: Dogan Fidan; Belgin Unal; Julia Critchley; Simon Capewell
Economic analysis of treatments reducing coronary heart disease mortality in England and Wales, 2000-2010.
QJM : monthly journal of the Association of Physicians 2007;100(5):277-89.
2005: Alexander T Cohen; C Hirst; B Sherrill; P Holmes; Dogan Fidan
Meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery.
The British journal of surgery 2005;92(11):1335-44.
2005: Alec H Miners; Martina Garau; Dogan Fidan; A J Fischer
Comparing estimates of cost effectiveness submitted to the National Institute for Clinical Excellence (NICE) by different organisations: retrospective study.
BMJ (Clinical research ed.) 2005;330(7482):65.
2005: SE Garner; Dogan Fidan; R R Frankish; Maria Judd; Tanveer Towheed; George Wells; Peter Tugwell
Rofecoxib for rheumatoid arthritis.
Cochrane database of systematic reviews (Online) 2005;(1):CD003685.
2005: SE Garner; Dogan Fidan; R Frankish; L Maxwell
Rofecoxib for osteoarthritis.
Cochrane database of systematic reviews (Online) 2005;(1):CD005115.
2005: Belgin Unal; Julia A Critchley; Dogan Fidan; Simon Capewell
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.
American journal of public health 2005;95(1):103-8.
2002: SE Garner; Dogan Fidan; R Frankish; M Judd; B Shea; T Towheed; George Wells; Peter Tugwell
Celecoxib for rheumatoid arthritis.
Cochrane database of systematic reviews (Online) 2002;(4):CD003831.
2002: SE Garner; Dogan Fidan; R Frankish; M Judd; T Towheed; George Wells; Peter Tugwell
Rofecoxib for the treatment of rheumatoid arthritis.
Cochrane database of systematic reviews (Online) 2002;(3):CD003685.
2002: SE Garner; Dogan Fidan; R Frankish; M Judd; T Towheed; George Wells; Peter Tugwell
Rofecoxib for the treatment of rheumatoid arthritis.
Cochrane database of systematic reviews (Online) 2002;(2):CD003685.
1999: C Packer; Dogan Fidan
DEC methods for appraising new drugs. Horizon scanning is important for emerging health technologies.
BMJ (Clinical research ed.) 1999;319(7215):1006; author reply 1006-7.